Antibody-peptide conjugates can be broadly classified under the well-known category of ADCs (antibody-drug conjugates)
Hyperuricemia and its related histopathological features on renal biopsy
Overview of Keros Therapeutics protein drug KER-065 [5]
By Indication, Type 2 Diabetes mellitus leads the market, due to high prevalence, strong glycemic control, and clinical benefits Type 2 Diabetes Mellitus (T2DM) dominates the GLP-1 receptor agonist market, with a 61.7% share in 2025 , driven by its high global prevalence
Results are best when the injections are part of a structured wellness plan
CJC-1295 and ipamorelin: the body recomposition duo This combination is arguably the most popular peptide stack in the fat loss space, and for good reason